News Kamada Ltd.

Equities

KMDA

IL0010941198

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:24:25 2024-04-18 am EDT			5-day change	1st Jan Change
1,909 ^ILa	+1.33%		-1.55%	-14.28%

Mar. 06	Transcript : Kamada Ltd., Q4 2023 Earnings Call, Mar 06, 2024
Mar. 06	Kamada Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Kamada Ltd., Q4 2023 Earnings Call, Mar 06, 2024	Mar. 06
Kamada: Q4 Earnings Snapshot	Mar. 06	AQ
Kamada : Reports Fiscal Year and Fourth Quarter 2023 Financial Results, CEO letter and presentation	Mar. 06	PU
Kamada Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 06	CI
Kamada : 20F 2023 Annual Report	Mar. 06	PU
Kamada Issues 2024 CEO Letter to Shareholders	Mar. 06	AQ
Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability	Mar. 06	AQ
Kamada Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Kamada Ltd. Provides Revenue Guidance for the Year 2024	Mar. 06	CI
Kamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results, and Provide 2024 Financial Guidance on March 6, 2024	Feb. 28	AQ
Kamada : Results of Annual General Meeting of Shareholders held on December 28, 2023	Dec. 28	PU
Kamada : Other Information - Form 6-K	Dec. 28	PU
PRISM MarketView Biotech Index Top Mover Spotlight: Kamada Ltd.	Dec. 08	AQ
Kamada, Kedrion Extend US Distribution Deal for Kedrab	Dec. 07	MT
Kamada Amends, Extends Kedrab Distribution Deal With Kedrion Biopharma; Shares Surge 20% Pre-Bell	Dec. 06	MT
Transcript : Kamada Ltd. - Special Call	Dec. 06
Top Premarket Gainers	Dec. 06	MT
Kamada Ltd. Announces the Execution of A Binding Memorandum of Understanding with Kedrion	Dec. 06	CI
Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years	Dec. 06	AQ
Transcript : Kamada Ltd., Q3 2023 Earnings Call, Nov 13, 2023	Nov. 13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Kamada Ltd.

Equities

KMDA

IL0010941198

Summary

Filters